TH87497B - 11-beta-hydroxystesteroid dehydrogenase-1 inhibitor Of type 2-1 diabetes - Google Patents
11-beta-hydroxystesteroid dehydrogenase-1 inhibitor Of type 2-1 diabetesInfo
- Publication number
- TH87497B TH87497B TH601004137A TH0601004137A TH87497B TH 87497 B TH87497 B TH 87497B TH 601004137 A TH601004137 A TH 601004137A TH 0601004137 A TH0601004137 A TH 0601004137A TH 87497 B TH87497 B TH 87497B
- Authority
- TH
- Thailand
- Prior art keywords
- type
- diabetes
- hydroxystesteroid
- dehydrogenase
- beta
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 239000000126 substance Substances 0.000 claims abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- -1 heteroaryyl Chemical group 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 abstract 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Abstract
ที่ได้รับการจัดเตรียมในนี้เป็นสารประกอบที่มีสูตร (I) (สูตรเคมี) (I) รวมทั้งเกลือของสิ่งเหล่านี้ที่สามารถยอมรับได้ทางเภสัชกรรม ในที่ซึ่งหมู่แทนที่เป็นเช่นเหล่านั้นที่ ได้รับการเปิดเผยในรายการจำเพาะ สารประกอบเหล่านี้, และองค์ประกอบทางเภสัชกรรมซึ่งมี สารประกอบเหล่านี้ เป็นประโยชน์สำหรับการบำบัดรักษาของโรคอย่างเช่น ตัวอย่างเช่น โรคเบาหวานแบบชนิด II และกลุ่มอาการเมแทบอลิก Prescribed herein are compounds with formula (I) (chemical formula) (I) as well as salts of them that are pharmacologically acceptable. In which the moo instead is such that Has been disclosed in a specific list These compounds, and their pharmaceutical constituents which have These compounds It is useful for the treatment of diseases such as type II diabetes mellitus and metabolic syndrome.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH87497A TH87497A (en) | 2007-11-09 |
| TH87497B true TH87497B (en) | 2007-11-09 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| EA201000050A1 (en) | SUBSTITUTED BICYCLOPLASTIC COMPOUNDS | |
| CY1118611T1 (en) | COMBINATIONS CONTAINING DERIVATIVES OF 6-benzyl-PHENYL-2-THEIOTETRAFDROPYRAN-3,4,5-TRIOLIS AS INHIBITORS OF cotransporter 1 AND 2 SODIUM-GLUCOSE FOR USE IN DIABETIC PATIENTS | |
| ATE477819T1 (en) | USE OF ORGANIC COMPOUNDS | |
| WO2007107470A3 (en) | Pyrazoles as 11-beta-hsd-1 | |
| WO2007060140A3 (en) | Inhibitors of diacyglycerol acyltransferase (dgat) | |
| EA201000886A1 (en) | ORGANIC COMPOUNDS | |
| ATE442349T1 (en) | DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS | |
| CL2007001006A1 (en) | COMPOUNDS DERIVED FROM PIPERIDINE U 8-AZA-BICICLO [3.2.1] OCTANO SUBSTITUTED; PHARMACEUTICAL FORMULATION; PRODUCT; AND USE FOR THE TREATMENT OR PREVENTION OF DISEASES AS DEPENDENT MELLITUS DIABETES, ARTHRITIS, OBESITY, DISLIPID | |
| WO2007125405A3 (en) | Substituted 2-amino-fused heterocyclic compounds | |
| WO2009097113A3 (en) | Oxazole and thiazole compounds as b-catenin modulators and uses thereof | |
| WO2016105118A3 (en) | Biaryl derivative as gpr120 agonist | |
| ATE528306T1 (en) | BENZOXAZEPINE COMPOUNDS, THEIR PREPARATION AND USE | |
| WO2008079610A3 (en) | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome | |
| WO2007038425A3 (en) | Anti-viral compouinds | |
| WO2008041134A3 (en) | Use of chlorine guanabenz derivatives for treating prion-based diseases | |
| TH87497B (en) | 11-beta-hydroxystesteroid dehydrogenase-1 inhibitor Of type 2-1 diabetes | |
| TH87497A (en) | 11-beta-hydroxystosterone dehydrogenase-1 inhibitor Of type 2-1 diabetes | |
| EA201070750A1 (en) | Octagydroquinolysis intended for the treatment of diabetes | |
| PA8851901A1 (en) | CYCLOPROPYL COMPOUNDS | |
| WO2008156331A3 (en) | Novel use of lignan compounds | |
| TH108044A (en) | Aminotetrahydropyran as an inhibitor of dipeptidyl peptidase-IV for therapeutic use Or prevention of diabetes | |
| TH97685A (en) | ||
| TH90122A (en) | Heterocyclic compound | |
| TH102404A (en) | A method of using substituted piperidine which enhances the action of P53. |